Abstract 4497: NYGC glioblastoma clinical outcomes pilot study: Discovering therapeutic potential in glioblastoma through integrative genomics

Current adjuvant therapeutic options for the treatment of Glioblastoma (GBM) are often determined by limited histological information. Additionally, most GBM clinical trials for targeted chemotherapeutic agents do not distinguish the genetic mutational tumor profiles of the patients recruited and ha...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 2016-07, Vol.76 (14_Supplement), p.4497-4497
Hauptverfasser:	Wrzeszczynski, Kazimierz O., Robine, Nicolas, Vacic, Vladimir, Emde, Anne-Katrin, Chen, Bo-Juen, Liao, Will, Arora, Kanika, Shah, Minita, Grabowska, Ewa A., Felice, Vanessa, Dikoglu, Esra, Reeves, Catherine, Frank, Mayu, Jobanputra, Vaidehi, Zody, Michael C., Bloom, Toby, Darnell, Robert B.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!